Analysts: GlaxoSmithKline PLC (GSK.N)

GSK.N on New York Stock Exchange

42.85USD
24 Dec 2014
Price Change (% chg)

$0.11 (+0.26%)
Prev Close
$42.74
Open
$42.74
Day's High
$42.90
Day's Low
$42.74
Volume
284,196
Avg. Vol
907,394
52-wk High
$56.73
52-wk Low
$41.29

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- December 25 Dec 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 2 3 3 4
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.75 2.50 2.50 2.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 2 10,943.80 11,855.60 10,031.90 11,344.10
Quarter Ending Mar-15 1 10,780.90 10,780.90 10,780.90 10,638.10
Year Ending Dec-14 4 37,233.10 39,590.80 35,704.40 42,848.90
Year Ending Dec-15 4 39,493.70 41,979.70 37,272.30 44,952.70
Earnings (per share)
Year Ending Dec-14 4 3.02 3.09 2.87 3.83
Year Ending Dec-15 4 2.98 3.15 2.64 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 10,139.10 9,428.82 710.28 7.01
Quarter Ending Jun-14 10,079.80 9,359.61 720.17 7.14
Quarter Ending Mar-14 9,846.03 9,317.58 528.45 5.37
Quarter Ending Dec-13 11,183.30 11,184.40 1.13 0.01
Quarter Ending Sep-13 10,808.80 9,765.00 1,043.82 9.66
Earnings (per share)
Quarter Ending Sep-14 0.40 0.93 0.53 129.97
Quarter Ending Dec-13 0.96 0.97 0.01 1.04
Quarter Ending Dec-12 0.72 1.04 0.32 44.22
Quarter Ending Jun-12 0.66 0.83 0.17 26.35
Quarter Ending Mar-12 0.69 0.85 0.16 23.49

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 10,943.80 10,943.80 10,943.80 10,943.80 11,344.10
Quarter Ending Mar-15 10,780.90 10,780.90 10,780.90 10,780.90 10,638.10
Year Ending Dec-14 37,233.10 37,233.10 37,594.60 37,594.60 42,848.90
Year Ending Dec-15 39,493.70 39,493.70 40,012.40 40,012.40 44,952.70
Earnings (per share)
Year Ending Dec-14 3.02 3.02 3.04 3.09 3.83
Year Ending Dec-15 2.98 2.98 3.06 3.12 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 0 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 1
Earnings
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks